Literature DB >> 25496871

Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals.

Thomas M Lancaster1, Lisa M Brindley2, Katherine E Tansey3, Rebecca C Sims3, Kiran Mantripragada3, Michael J Owen4, Julie Williams4, David E J Linden5.   

Abstract

INTRODUCTION: Genome-wide association studies identify rs11136000 in the CLU gene, which codes for Apolipoprotein J/Clusterin, as a significant risk variant for Alzheimer's disease (AD). However, the mechanisms by which this variant confers susceptibility remain relatively unknown.
METHODS: Eighty-five healthy Caucasian participants underwent functional magnetic resonance imaging during a working memory (WM) task and were genotyped for CLU rs11136000/APOE loci.
RESULTS: Here we show that young individuals with the CLU rs11136000 risk variant (C) have higher activation levels in memory-related prefrontal and limbic areas during a WM task. We also found subtle reductions in gray matter in the right hippocampal formation in carriers of the risk variant. DISCUSSION: We suggest that this pattern of multimodal imaging results may reflect incipient structural differences and inefficient functional activation. This study supports accumulating evidence suggesting that genetic risk for AD affects the neural networks associated with memory in healthy individuals.
Copyright © 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; CLU; DLPFC; Hippocampus; Imaging genetics; fMRI; rs11136000

Mesh:

Substances:

Year:  2014        PMID: 25496871     DOI: 10.1016/j.jalz.2014.10.012

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  15 in total

1.  Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.

Authors:  Davide Seripa; Francesco Panza; Giulia Paroni; Grazia D'Onofrio; Paola Bisceglia; Carolina Gravina; Maria Urbano; Madia Lozupone; Vincenzo Solfrizzi; Alessandra Bizzarro; Virginia Boccardi; Chiara Piccininni; Antonio Daniele; Giancarlo Logroscino; Patrizia Mecocci; Carlo Masullo; Antonio Greco
Journal:  Mol Neurobiol       Date:  2017-06-19       Impact factor: 5.590

2.  Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis.

Authors:  Zhaozhong Zhu; Yifei Lin; Xihao Li; Jane A Driver; Liming Liang
Journal:  Hum Genet       Date:  2019-02-25       Impact factor: 4.132

Review 3.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 4.  Microglial malfunction: the third rail in the development of Alzheimer's disease.

Authors:  Siddhita D Mhatre; Connie A Tsai; Amanda J Rubin; Michelle L James; Katrin I Andreasson
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

Review 5.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

6.  Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene.

Authors:  Lihua Qiu; Yong He; Hehan Tang; Yi Zhou; Jinhong Wang; Weiwei Zhang; Guangxiang Chen; Fei Zhao; Tingxue Ouyang; Bin Ju; Zhengyan Li; Lanlan Wang; Ling Zou; Qiyong Gong
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 7.  Magnetoencephalography as a Tool in Psychiatric Research: Current Status and Perspective.

Authors:  Peter J Uhlhaas; Peter Liddle; David E J Linden; Anna C Nobre; Krish D Singh; Joachim Gross
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-04

Review 8.  The multiplex model of the genetics of Alzheimer's disease.

Authors:  Rebecca Sims; Matthew Hill; Julie Williams
Journal:  Nat Neurosci       Date:  2020-02-28       Impact factor: 24.884

9.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Authors:  Mark T W Ebbert; Kevin L Boehme; Mark E Wadsworth; Lyndsay A Staley; Shubhabrata Mukherjee; Paul K Crane; Perry G Ridge; John S K Kauwe
Journal:  Alzheimers Dement       Date:  2015-10-09       Impact factor: 21.566

10.  Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.

Authors:  Rongrong Cai; Jing Han; Jie Sun; Rong Huang; Sai Tian; Yanjue Shen; Xue Dong; Wenqing Xia; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2016-07-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.